Pureos Bioventures
Status
ACTIVE
Global HQ
Schwyz, Switzerland
Countries of investment
- United Kingdom
Investment stages
- Seed
- Series A
- Series B
Industries
- Health Tech
- Biotechnology
- AI
- Data Science
About
Pureos Bioventures is a venture capital firm dedicated to investing in private companies that are pioneering the development of innovative therapeutics. Specializing in next-generation biological drugs, Pureos Bioventures aims to accelerate the advancement of treatments for severe diseases, ultimately enhancing patient outcomes and quality of life. By leveraging deep industry expertise and strategic partnerships, the firm empowers its portfolio companies to bring transformative solutions to the healthcare landscape.
Pureos Bioventures is a venture capital firm dedicated to investing in private companies that are pioneering the development of innovative therapeutics. Specializing in next-generation biological drugs, Pureos Bioventures aims to accelerate the advancement of treatments for severe diseases, ultimately enhancing patient outcomes and quality of life. By leveraging deep industry expertise and strategic partnerships, the firm empowers its portfolio companies to bring transformative solutions to the healthcare landscape.
Investment Thesis
Pureos Bioventures invests venture capital in private innovative drug development companies, with an emphasis on the next generation of biological drugs and drug formats. They strive to impact patients’ lives by advancing innovative treatments for severe diseases.
Manager's Experience
With a strong background in technology and life sciences, the fund manager has successfully executed over 50 deals across North America and Europe. Their strategic style emphasizes a data-driven approach, leveraging in-depth market analysis to identify high-potential opportunities. Notable exits include several successful IPOs and acquisitions, reinforcing their expertise in guiding companies through various investment stages. The manager’s operator-first mentality fosters deep collaboration with portfolio companies, driving innovation and growth in key sectors.
Team
Martin Muenchbach
Klaus Breiner
Dominik Escher